Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Astellas, Seagen Announce PADCEV Trial Results for Urothelial Cancer

americanpharmaceuticalreviewFebruary 18, 2021

Tag: Astellas , Seagen , Padcev , urothelial cancer , EV-301

PharmaSources Customer Service